
    
      The result of treatment in relapsed and refractory gastric cancer is still not satisfactory.
      For the moment, the combination of 5-Fu and cisplatin is regularly used. Capecitabine and
      Oxaliplatin are new generation drugs of 5-Fu and cisplatin. The current study is to evaluate
      the efficacy and toxicity of this combination.
    
  